- Report
- March 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- March 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- May 2023
- 160 Pages
Global
From €5827EUR$5,999USD£5,026GBP
- Book
- December 2019
- 560 Pages
- Book
- December 2019
- 560 Pages
- Book
- March 2019
- 480 Pages
- Book
- September 2016
- 680 Pages
- Book
- April 2012
- 1272 Pages
- Book
- February 2015
North America
The vomiting market within the context of Gastroenterology is a subset of the larger Gastroenterology market, which focuses on the diagnosis and treatment of diseases related to the digestive system. Vomiting is a symptom of many gastrointestinal disorders, and the market is focused on providing treatments and medications to alleviate the symptom. This includes antiemetics, which are drugs that reduce nausea and vomiting, as well as other treatments such as dietary changes and lifestyle modifications. Additionally, the market includes diagnostic tests and imaging techniques to identify the underlying cause of the vomiting.
The vomiting market is a growing field, as the prevalence of gastrointestinal disorders increases. It is expected to continue to grow in the coming years, as new treatments and medications are developed.
Some companies in the vomiting market include Novartis, GlaxoSmithKline, Merck, Pfizer, and Sanofi. Show Less Read more